Search Results 211-220 of 18183 for crohns disease

1. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease ... and stage of disease, and previous ...

2. A Study of Vedolizumab in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) - Mayo Clinic

   A Study of Vedolizumab in Pediatric Participants With Ulcerative Colitis (UC) or Crohn's Disease (CD) ... and stage of disease, and previous treatments or health ...

3. Comparing modalities for detecting dysplasia in patients with IBD - Mayo Clinic

   People with inflammatory bowel disease (IBD), such as Crohn's disease and ulcerative colitis, are at increased risk of developing colorectal cancer compared ...

4. Edward V. Loftus, Jr., M.D. - Mayo Clinic Faculty Profiles

   Incidence and prevalence of Crohn's disease and ulcerative colitis. Unusual and unforeseen complications of inflammatory bowel disease. Clinical trials of ...

5. Filgotinib in the Induction and Maintenance of Remission in Adults With Moderately to Severely Active Crohn's Disease - Mayo Clinic

   ... during induction and maintenance treatment of moderately to severely active Crohn's disease (CD) in participants who are biologic-naive and biologic-experienced ...

6. Is a hepatitis B immunity check needed for IBD patients? - Mayo Clinic News Network

   Inflammatory bowel disease (IBD), an autoimmune disease that involves chronic inflammation of tissues in the digestive tract, affects about 1.6 million ...

7. Frequent bowel movements Causes - Mayo Clinic

   Accessed Oct. 22, 2020. What is inflammatory bowel disease (IBD)? Centers for Disease Control and Prevention. https://www.cdc.gov/ibd/what-is-IBD.htm. Accessed ...

8. A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of ABT-494 for the Induction of Symptomatic and Endoscopic Remission in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Immunomodulators or Anti-TNF Therapy - Mayo Clinic

   To determine the efficacy and safety of multiple doses of ABT-494 in subjects with moderately to severely active Crohn's Disease with a history of inadequate ...

9. Study to Better Understand the Development of Irritable Bowel Disease (IBD) and Related Diseases as a Step Toward Improving Disease Outcomes. - Mayo Clinic

   The purpose of this study is to better understand disease development of Irritiable Bowel Disease (IBD) and related diseases as a step to improving disease ...

10. Collection of Blood in Patients with Inflammatory Bowel Disease - Mayo Clinic

    The blood and urine samples and quality of life data will be used for future research of IBD at Mayo Clinic and future research at Mayo Clinic to learn about, ...